rs267607969
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000251.3(MSH2):c.1661+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★★).
Frequency
Consequence
NM_000251.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460546Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726662
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Lynch syndrome 1 Pathogenic:2
- -
This variant is considered pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function. mRNA analysis has demonstrated abnormal mRNA splicing occurs [PMID: 18561205]. -
not provided Pathogenic:2
- -
Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Observed in multiple individuals with a personal and/or family history consistent with pathogenic variants in this gene (Parc et al., 2003; Kamiza et al., 2015; de Angelis de Carvalho et al., 2020), at least one with concordant tumor studies (Stormorken et al., 2005); This variant is associated with the following publications: (PMID: 25525159, 33825202, 16142001, 31830689, 26053027, 31773066, 20587412, 32659967, 12624141, 16034045) -
Lynch syndrome Pathogenic:1
Interrupts canonical donor splice site -
Hereditary nonpolyposis colorectal neoplasms Pathogenic:1
This sequence change affects a donor splice site in intron 10 of the MSH2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in MSH2 are known to be pathogenic (PMID: 15849733, 24362816). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with Lynch syndrome (PMID: 12624141, 16034045, 16142001, 21642682). This variant is also known as IVS10+1G>A. ClinVar contains an entry for this variant (Variation ID: 90719). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1661+1G>A intronic pathogenic mutation results from a G to A substitution one nucleotide after coding exon 10 of the MSH2 gene. This variant has been reported in multiple Lynch syndrome/HNPCC families and is also referred to as IVS10+1G>A (Bécouarn Y et al. Gastroenterol. Clin. Biol.;29:667-75; Parc Y et al. J. Med. Genet., 2003 Mar;40:208-13; Stormorken AT et al. J. Clin. Oncol., 2005 Jul;23:4705-12; Bonadona V et al. JAMA, 2011 Jun;305:2304-10). Two pathogenic variants, c.1661+1G>T and c.1661+2T>C, which also affect this canonical splice site, have also been reported (Papp J et al. World J. Gastroenterol. 2007 May;13(19):2727-32; Ambry internal data). This nucleotide position is highly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to abolish the native splice donor site; however, direct evidence is unavailable. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at